Front. Chem. Frontiers in Chemistry Front. Chem. 2296-2646 Frontiers Media S.A. 10.3389/fchem.2019.00804 Chemistry Correction RETRACTED: Corrigendum: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents Arjun H. A. 1 Elancheran Ramakrishnan 1 Manikandan N. 2 Lakshmithendral K. 1 Ramanathan Muthiah 2 Bhattacharjee Atanu 3 Lokanath N. K. 4 Kabilan Senthamaraikannan 1 * 1Drug Discovery Lab, Department of Chemistry, Annamalai University, Chidambaram, India 2Department of Pharmacology, PSG College of Pharmacy, Coimbatore, India 3Computational Biology Laboratory, Department of Biotechnology & Bioinformatics, North Eastern Hill University, Shillong, India 4Department of Physics, University of Mysore, Mysore, India

Edited and reviewed by: Greta Varchi, Consiglio Nazionale delle Ricerche (Bologna), Italy

 *Correspondence: Senthamaraikannan Kabilan profdrskabilanau@gmail.com

This article was submitted to Medicinal and Pharmaceutical Chemistry, a section of the journal Frontiers in Chemistry

 26 11 2019 2019 7 804 23 10 2019 07 11 2019 Copyright © 2019 Arjun, Elancheran, Manikandan, Lakshmithendral, Ramanathan, Bhattacharjee, Lokanath and Kabilan. 2019 Arjun, Elancheran, Manikandan, Lakshmithendral, Ramanathan, Bhattacharjee, Lokanath and Kabilan

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents by Arjun, H. A., Elancheran, R., Manikandan, N., Lakshmithendral, K., Ramanathan, M., Bhattacharjee, A., et al. (2019). Front. Chem. 7:474. doi: 10.3389/fchem.2019.00474 androgen receptor prostate cancer benzohydrazide molecular docking molecular dynamics ADME

In the original article, there was a mistake in the Figure 4 as published. Figure 4 was not appropriated for the tested compound 6g. The corrected Figure 4 appears below.

The morphological changes in 6g and Zebularine treated in prostate cancer cell line. The treated and untreated cells were stained with Acridine orange and Ethidium bromide and observed under an inverted fluorescent microscope. Live cells appear green, late apoptotic cells are appearing orange in color, and necrotic cells are colored red.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.